CYTK

Cytokinetics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Value↓ 0/10
Cytokinetics sales and earnings growth
CYTK Growth
Low
  • Revenue Y/Y↑ 376.56%
  • EPS Y/Y↓ -24.33%
  • FCF Y/Y↓ -33.77%
Cytokinetics gross and profit margin trends
CYTK Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↓ -891.60%
  • ROIC 5Y↓ -32.99%
Cytokinetics net debt vs free cash flow
CYTK Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 2.2
  • Interest coverage↓ -16.2

Cytokinetics stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Biotechnology stocks ↗